Many Hodgkin lymphoma patients at Seattle Cancer Care Alliance (SCCA) receive promising therapies by joining clinical trials. These research studies are done by physician-scientists from SCCA and Fred Hutchinson Cancer Research Center. They test new treatments or new ways to use current treatments.
We have clinical trials for all stages of Hodgkin lymphoma. These therapies work well on Hodgkin lymphoma:
- Chemotherapy regimens
- Antibody therapies
In the past decade, research into antibody therapies and immunotherapies has found new ways to control Hodgkin lymphoma or put it into remission. SCCA is a national leader in advancing these and other options, bringing new hope to patients.
When your care team designs your treatment plan, they will give you the choice to join clinical trials that match your situation. If you decide to join one, you will see the same physicians and nurses as you would for standard therapy.
Your care team will talk with you about if you might want to join a particular study and why. This can help you make the decision that is best for you.
I see what you go through when you’re diagnosed with cancer as an adjustment. Your expectations change. The mountains that you climbare a little less tall than the ones you climbed before. But it doesn’t change what you do; it just changes the magnitude. - Holger Herbert, SCCA patient since 2004
Improving survival and reducing side effects in Hodgkin lymphoma
Learn about the clinical trial and research Fred Hutch did on using PET imaging to guide treatment for Hodgkin lymphoma.